MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)

Clinical trial NCT00837577 · COMPLETED

Trial details

NCT number: NCT00837577
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Non-Insulin-Dependent

Start date: 2009-02-05
Primary completion: 2010-08-11
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.